Skip to main content

Closed

RIGL: Rigel Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

49thpctl

Volume

0.44×avg

Market Cap

681.06MUSD

P/E Ratio

1.8TTM

Div Yield

-ann

Rigel Pharmaceuticals, Inc.

RIGLNASDAQ·USD·Closed

Rigel Pharmaceuticals, Inc.

RIGLNASDAQ·USD·Closed

$36.81

−3.28%

$36.81

−$1.25 (3.28%)

52W Range

49thpctl

Volume

0.44×avg

Mkt Cap

681.06MUSD

P/E

1.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings